Pages that link to "Q24317382"
Jump to navigation
Jump to search
The following pages link to Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II) (Q24317382):
Displaying 50 items.
- Complement factor H (Q581194) (← links)
- Structure of complement fragment C3b-factor H and implications for host protection by complement regulators (Q24646723) (← links)
- Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice (Q24651118) (← links)
- Complement factor H and the hemolytic uremic syndrome (Q24676234) (← links)
- Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN (Q26741542) (← links)
- Overview of C3 Glomerulopathy (Q26747262) (← links)
- Complement factor H related proteins (CFHRs) (Q26851489) (← links)
- Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion (Q27008508) (← links)
- Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism (Q27644071) (← links)
- MPGN II--genetically determined by defective complement regulation? (Q28267245) (← links)
- The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models (Q28272816) (← links)
- Production of biologically active complement factor H in therapeutically useful quantities (Q28300280) (← links)
- Factor H genotype-phenotype correlations: lessons from aHUS, MPGN II, and AMD. (Q33371793) (← links)
- Complete factor H deficiency-associated atypical hemolytic uremic syndrome in a neonate (Q33374215) (← links)
- Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains (Q33375335) (← links)
- Pathogenesis and prognosis of thrombotic microangiopathy (Q33375692) (← links)
- Ocular involvement in hemolytic uremic syndrome due to factor H deficiency--are there therapeutic consequences? (Q33375833) (← links)
- Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis (Q33377727) (← links)
- Translational mini-review series on complement factor H: genetics and disease associations of human complement factor H. (Q33377799) (← links)
- Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. (Q33378236) (← links)
- Complement factor H: using atomic resolution structure to illuminate disease mechanisms (Q33382097) (← links)
- The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci (Q33384198) (← links)
- Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance (Q33396948) (← links)
- Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway (Q33403738) (← links)
- Dynamics of complement activation in aHUS and how to monitor eculizumab therapy (Q33416519) (← links)
- Molecules Great and Small: The Complement System (Q33419651) (← links)
- Molecular Basis of Factor H R1210C Association with Ocular and Renal Diseases. (Q33425911) (← links)
- Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders (Q33437488) (← links)
- Childhood-onset dense deposit disease: a rare cause of proteinuria (Q33906517) (← links)
- Membranoproliferative glomerulonephritis (Q33920373) (← links)
- Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice (Q34005720) (← links)
- Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation (Q34162206) (← links)
- Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN. (Q34427591) (← links)
- Defining the complement biomarker profile of C3 glomerulopathy (Q34455125) (← links)
- Current concepts in C3 glomerulopathy (Q34574482) (← links)
- Dense deposit disease. (Q35124165) (← links)
- Allelic variants of complement genes associated with dense deposit disease (Q35142753) (← links)
- Treatment options for C3 glomerulopathy (Q35624672) (← links)
- Kidney function, albuminuria and age-related macular degeneration in NHANES III. (Q35639388) (← links)
- Dense deposit disease in Korean children: a multicenter clinicopathologic study (Q36310131) (← links)
- Mechanisms of disease: the complement system in renal injury--new ways of looking at an old foe. (Q36801018) (← links)
- New approaches to the treatment of dense deposit disease (Q36860946) (← links)
- C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation (Q36891110) (← links)
- The Genetics of Ultra-Rare Renal Disease (Q37032691) (← links)
- Translational mini-review series on complement factor H: structural and functional correlations for factor H. (Q37032788) (← links)
- The C-terminus of complement factor H is essential for host cell protection (Q37238656) (← links)
- Dense deposit disease and C3 glomerulopathy (Q37286653) (← links)
- Factor I and factor H deficiency in renal diseases: similar defects in the fluid phase have a different outcome at the surface of the glomerular basement membrane. (Q37306354) (← links)
- Novel biomarkers in glomerular disease (Q37658483) (← links)
- Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. (Q38048606) (← links)